Sun et al. reported that DEK overexpression was an independent prognostic factor along with histological grade and TNM stage, and also influenced OS rates of pancreatic cancer in grade 1 and 2, and early-stage groups [26]. This evidence concerns the gene DEK and pancreatic neoplasm.